1. Neurokinin 1 Receptor Antagonists for Pruritus

   • Majid Alam
   • Joerg Buddenkotte
   • Martin Steinhoff

   Leading Article Open access 06 March 2021 Pages: 621 - 634

2. Fabry Disease: The Current Treatment Landscape

   • Malte Lenders
   • Eva Brand

   Review Article Open access 15 March 2021 Pages: 635 - 645

   

3. Pathophysiology and Management of Variceal Bleeding

   • Saleh A. Alqahtani
   • Sunguk Jang

   Review Article 12 March 2021 Pages: 647 - 667

   

4. Novel Treatments for Mantle Cell Lymphoma: From Targeted Therapies to CAR T Cells

   • Danielle Wallace
   • Patrick M. Reagan

   Review Article 30 March 2021 Pages: 669 - 684

   

5. Prior Treatment with Statins is Associated with Improved Outcomes of Patients with COVID-19: Data from the SEMI-COVID-19 Registry

   • José David Torres-Peña
   • Luis M. Pérez-Belmonte
   • for the SEMI-COVID-19 Network

   Original Research Article 29 March 2021 Pages: 685 - 695

   

6. Entrectinib: A Review in NTRK+ Solid Tumours and ROS1+ NSCLC

   • James E. Frampton

   Adis Drug Evaluation Open access 19 April 2021 Pages: 697 - 708

7. Indacaterol/Glycopyrronium/Mometasone: A Review in Asthma

   • Hannah A. Blair

   Adis Drug Evaluation 19 April 2021 Pages: 709 - 719

8. Vericiguat: First Approval

   • Anthony Markham
   • Sean Duggan

   AdisInsight Report 26 March 2021 Pages: 721 - 726

   

9. Surufatinib: First Approval

   • Yahiya Y. Syed

   AdisInsight Report 31 March 2021 Pages: 727 - 732

   

10. Correction to: Nintedanib: A Review in Fibrotic Interstitial Lung Diseases

    • Yvette N. Lamb

    Correction 13 April 2021 Pages: 733 - 733

11. Correction to: Secukinumab: A Review in Psoriatic Arthritis

    • Hannah A. Blair

    Correction Open access 15 April 2021 Pages: 735 - 735

12. Correction to: Ravulizumab: A Review in Atypical Haemolytic Uraemic Syndrome

    • Yahiya Y. Syed

    Correction Open access 19 April 2021 Pages: 737 - 737